HCA Healthcare IncHCA
Price$423.39Intrinsic value$385.939% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $385.93median of 5 methods · middle span $367-$760based on filings through 31 Mar 2026
Market Price $423.39Price as of 1 Oct 2026
Margin of Safety -8.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 7.9% (near-term consensus, capped) · years 2–5: 7.8%/yr (balance of the path).7.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 67.8%Yr 77.8%Yr 87.8%Yr 97.8%Yr 107.8%
7.8% → 7.8%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.3%Yr 126.8%Yr 136.4%Yr 145.9%Yr 155.4%Yr 164.9%Yr 174.4%Yr 184.0%Yr 193.5%Yr 203.0%
7.8% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)18.8%
Discount rate (cost of equity) 9.8%
Volatility vs market (adjusted beta)1.07

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetHCA Healthcare IncHCAHealth Care
Valuation
P/E14.6×
P/S1.2×
P/B—
EV / Revenue1.8×
EV / EBITDA—
Profitability
Gross margin—
Operating margin12.8%
Net margin8.9%
FCF margin10.4%
Returns
ROE—
ROA11.1%
ROIC16.7%
Growth
Revenue growth (YoY)8.2%
5-yr fwd EPS growth7.8%
Financial strength
Debt / Equity—
Current ratio0.83×
Altman Z-Score2.4
Interest coverage—
Dividend yield0.5%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.